NDC Package 51662-1213-1 25% Dextrose Infant

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51662-1213-1
Package Description:
1 SYRINGE, PLASTIC in 1 CARTON / 10 mL in 1 SYRINGE, PLASTIC
Product Code:
Proprietary Name:
25% Dextrose Infant
Non-Proprietary Name:
25% Dextrose Infant
Substance Name:
Dextrose Monohydrate
Usage Information:
25% Dextrose Injection is indicated in the treatment of acute symptomatic episodes of hypoglycemia in the neonate or older infant to restore depressed blood glucose levels and control symptoms. Other drugs, such as epinephrine and glucagon, should be considered in patients unresponsive or intolerant to dextrose (glucose). Oral feeding of dextrose may be necessary in infants with frequently recurring hypoglycemic episodes or to prevent recurrences due to hyperinsulinemia.25% Dextrose Injection also provides a minimal source of carbohydrate calories.
11-Digit NDC Billing Format:
51662121301
NDC to RxNorm Crosswalk:
  • RxCUI: 727518 - dextrose 25 % in 10 ML Prefilled Syringe
  • RxCUI: 727518 - 10 ML glucose 250 MG/ML Prefilled Syringe
  • RxCUI: 727518 - 10 ML dextrose 25 % Prefilled Syringe
  • RxCUI: 727518 - dextrose 2.5 GM per 10 ML Prefilled Syringe
  • RxCUI: 727518 - dextrose 2500 MG per 10 ML Prefilled Syringe
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hf Acquisition Co. Llc, Dba Health First
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA019445
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-19-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51662-1213-1?

    The NDC Packaged Code 51662-1213-1 is assigned to a package of 1 syringe, plastic in 1 carton / 10 ml in 1 syringe, plastic of 25% Dextrose Infant, a human prescription drug labeled by Hf Acquisition Co. Llc, Dba Health First. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 51662-1213 included in the NDC Directory?

    Yes, 25% Dextrose Infant with product code 51662-1213 is active and included in the NDC Directory. The product was first marketed by Hf Acquisition Co. Llc, Dba Health First on August 19, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51662-1213-1?

    The 11-digit format is 51662121301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151662-1213-15-4-251662-1213-01